Bio

Ellen Codd, Principal of Codd Consulting, LLC, brings over 25 years experience in the pharmaceutical sector (Johnson & Johnson and GlaxoSmithKline) to bear on health issues disproportionately affecting those in resource poor countries. Current projects focus on the preparation of Orphan Drug Applications, INDs, NDAs and related activities aimed at bringing new medicines to treat neglected/orphan diseases. In collaboration with global health professionals, Ellen represents projects in discussions with the FDA, serves as an interface for work conducted via the NIH or in contract labs, and uses the scientific literature to progress projects to clinical study. Recognized for her ability to bring together diverse groups to successful project outcomes, Ellen draws on strong organizational and strategic skills, which have resulted in the advancement and approval of new medicines.

Ellen Codd has an M.S. in biochemistry and has studied at the Summer Institute of Tropical Medicine at Johns Hopkins Bloomberg School of Public Health. A member of the American Society of Pharmacology and Experimental Therapeutics, the Society for Neuroscience and the American Pain Society, she has 80+ peer-reviewed publications, numerous abstracts and 15 issued patents.